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Abstract
Background: Supravalvular aortic stenosis (SVAS) is one of the congenital cardio-
vascular diseases characterized by stenosis of the aorta. The stenotic lesions occur 
anywhere above the aortic valve in the aortic tree as well as pulmonary arteries and 
eventually leads to circulatory failure. The disease gene has been identified on the 
elastin gene (ELN) and two types of SVAS have been categorized; a familial type and 
an isolated type with the de novo mutation.
Methods: Fluorescent In situ hybridization (FISH) analysis and gene sequencing were 
performed in a two‐generation family in which severe form of SVAS was diagnosed.
Results: None of the patients tested showed microdeletion of ELN, LIMK1, and 
D7S613. A novel nonsense mutation of ELN (c.160G>T (p.(Gly54*)), RNA not 
analyzed) was found in exon 3 in three members; two of them died suddenly due to 
rapid progression of SVAS with possible arrhythmia in early infancy. A point muta-
tion in the 5’ untranslated region, which was previously suggested to be associated 
with SVAS, did not co‐segregate with the SVAS phenotype and found to be SNPs.
Conclusion: Our report shows a broad spectrum of clinical features in family mem-
bers sharing the identical mutations, suggesting a potential contribution of modifier 
gene(s) or interactions with environmental factors.
K E Y W O R D S
ELN, modifier gene, pulmonary artery stenosis, sudden death, supravalvular aortic stenosis
2 of 5 |   SUGIYAMA et Al.
1 |  INTRODUCTION
Supravalvular aortic stenosis ([SVAS]; OMIM 185500) is 
a congenital narrowing of the lumen of ascending aorta 
immediately above the aortic valve. SVAS related to 
elastin (ELN; OMIM 130160) gene mutations frequently 
affects branch pulmonary arteries (PA) and coronary ar-
teries, whereas descending aorta, cerebral arteries, and 
renal arteries are usually spared. Narrowed lumens of the 
aorta and PA provoke increased resistance to systemic and 
pulmonary blood flow, resulting in hypertrophy of both 
ventricles. In some cases, life‐threatening ventricular ar-
rhythmias in association with myocardial ischemia develop 
due to coronary stenosis or hypertrophy, leading to sudden 
death. SVAS is a major clinical manifestation of Williams‐
Beuren syndrome ([WBS], OMIM 194050), which affects 
1 in 20,000 people (Metcalfe et al., 2000). In WBS, autoso-
mal dominant mutation is located in chromosome 7q11.23, 
and ELN, which is included in this region, is known to be 
responsible for SVAS (Curran et al., 1993). SVAS may also 
be present in a non‐syndromic condition, in which frame-
shift or nonsense mutations are proposed to cause func-
tional haploinsufficiency (Micale et al., 2010).
1.1 | Patients’ report
The female proband (III‐1) was born at 39w2d of gesta-
tion after an uncomplicated pregnancy with birth weight of 
3,334 g (Figure 1). When she was delivered, her parents were 
29 years old. Heart murmur was pointed out at 6 days of age, 
and echocardiography revealed SVAS and pulmonary artery 
stenosis (Figure 2a). She did not have appearance of WBS. 
At 13 days of age, echocardiography revealed that diameters 
of the annulus and supravalvular region of the aorta were 6.2 
and 3.7 mm, respectively, and that pressure gradient (PG) of 
the left ventricular outflow tract (LVOT) was estimated at 
23  mmHg by continuous wave Doppler echocardiography. 
The whole PA appeared hypoplastic and PG of the right ven-
tricular outflow tract (RVOT) was estimated at 64 mmHg. 
Electrocardiogram (ECG) revealed single premature ven-
tricular contractions and slight ST‐T changes, followed by 
non‐sustained monomorphic ventricular tachycardia (VT) 
(ventricular rate, 200  bpm). VT was sensitive to adeno-
sine triphosphate (ATP) and suppressed by beta‐blockers. 
Contrast cardiac computed tomography (CT) conducted at 
age 32 days showed SVAS and generalized hypoplastic PA 
(Figure 2b).
The other arterial lesions, including coarctation of the 
aorta or coronary arterial stenosis, were not observed. 
Although the patient showed normal growth without ap-
parent symptoms of heart failure or systemic hypertension 
(blood pressure was 70/33 mmHg) during the first 2 months 
of life, the LVOT‐ and RVOT‐PG were gradually increased 
to 58 and 90  mmHg, respectively, LV hypertrophy pro-
gressed, and moderate mitral regurgitation appeared. This 
patient died suddenly at home at age 74 days. Her height was 
F I G U R E  1  Pedigree of the family, 
showing autosomal dominant inheritance. 
Circles indicate females and squares indicate 
males. White indicates healthy individuals, 
black indicates Supravalvular aortic stenosis 
(SVAS), and diagonal bar shows deceased. 
II‐2 underwent patch aortoplasty for SVAS 
at 15 years of age. III‐1 and III‐2 had sudden 
death at 2 months old. III‐3 did not have a 
clinical diagnosis of SVAS
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55.3 cm and body weight was 4,900 g at the last follow‐up 
prior to death.
Medical history revealed that mother of the proband (II‐2) 
underwent patch aortoplasty for SVAS when she was 15 years 
old. The hypoplastic pulmonary artery was not reported on 
her surgery record, and clinical course after the surgery was 
uneventful. Furthermore, there was the other family member 
who died young (at age 16, I‐1) although details of his clin-
ical course, including the cause of death, were not known.
The mother of proband (II‐2) became pregnant after the 
proband's death. The fetus was screened regularly for possible 
inheritance of SVAS by fetal echocardiography. No cardiovas-
cular abnormalities were found except that LVOT blood flow 
was slightly accelerated (2.0 m/s) without an apparent narrowing 
of the aorta during the 3rd trimester. This baby (III‐2) was born 
at 38w5d of gestation with birth weight of 2,914 g after an un-
complicated pregnancy. At this time, the parents were 31 years 
old. Auscultation of the chest revealed systolic murmur, but he 
showed normal growth without signs of heart failure. Systemic 
hypertension was not noted (blood pressure was 53/34 mmHg). 
On echocardiography at 38 days of age, diameters of the annu-
lus and supravalvular region of the aorta were 6.5 and 4.5 mm, 
respectively, and PG of LVOT was estimated at 67  mmHg. 
Pulmonary arteries were slightly hypoplastic and PG of RVOT 
was estimated at 43  mmHg. LVOT‐PG gradually progressed. 
Although ECG did not show ST depression, the left ventricle 
(LV) appeared slightly hypertrophic on echocardiogram at one 
month of age. Patch aortoplasty for SVAS was considered as 
a management option, but this baby died suddenly at home at 
89 days of age. The baby was 53.5 cm with 4,886 g at the last 
follow‐up prior to death.
The third baby (III‐3) was born at 40 weeks of gestation 
with birth weight of 3,147 g. Echocardiography and contrast 
cardiac CT confirmed the diagnosis of vascular ring formed by 
the right aortic arch, and aberrant left subclavian fused with the 
left common carotid artery, with the Kommerell diverticulum, 
which had been suspected prenatally by fetal echocardiography. 
Since this male infant did not present with dyspnea or esoph-
ageal obstruction due to the vascular ring, surgical repair was 
not indicated. Intracardiac structure was normal, and neither 
SVAS nor pulmonary arterial stenosis was observed although 
mild aortic regurgitation was detected. Extracardiac malforma-
tions included left cheilognathopalatoschisis, and left acces-
sory auricle. At the last follow‐up of 8 months of age, he was 
67.6 cm height with 7,660 g weight and growing well.
2 |  MATERIALS AND METHODS
2.1 | Ethical compliance
All the family members were Japanese. A written informed con-
sent was obtained. The study protocol was approved by the re-
search ethics committee of Ibaraki Children's Hospital (29A‐2).
2.2 | Fluorescent in situ hybridization
Fluorescent In situ hybridization (FISH) analysis using the 
probe in situ hybridization (ish) 7q11.23 was performed to 
detect microdeletion of ELN, LIMK1 (OMIM 601329), and 
D7S613, which has been established for diagnosis of Williams 
syndrome (Elcioglu, Mackie‐Ogilvie, Daker, & Berry, 1998).
2.3 | Gene sequencing
Genomic DNA was extracted from the blood of probands in 
the respective families (II‐2, III‐1, III‐2, and III‐3) and a healthy 
control according to manufacturer's instructions (QIAGEN). 
ELN exons were amplified by PCR and the PCR product was 
cleaned up by ExoSAP‐IT® (Thermo Fisher Sciencific) to re-
move unincorporated dNTPs and primers. The products were 
subjected to Sanger sequencing with Big DyeTM Terminater 
v3.1 Cycle Sequencing Kit (Thermo Fisher Scientific). All 
34 exons of ELN (NM_000501.2) were examined by 3130xl 
Genetic Analyzer (Thermo Fisher Scientific). SnapGene Viewer 
F I G U R E  2  Cardiovascular images of the proband (III‐1). (a) Left ventricular long‐axis view of echocardiogram, showing supravalvular 
aortic stenosis (arrow). Diameters of aortic annulus and supravalvular portion are 6.2 and 3.7 mm, respectively. (b) Multidetector computer 
tomographic reconstruction image showing supravalvular aortic stenosis (arrow, Supravalvular aortic stenosis) and slight hypoplasia of whole aorta 
(left panel). The posterior view demonstrates markedly hypoplastic pulmonary arteries (right panel). Ao, aorta; d‐Ao, descending aorta; LA, left 
atrium; LPA, left pulmonary artery; LV, left ventricle; RPA, right pulmonary artery
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software (Ver.4.2.11) was used to analyze the results and human 
reference gene (GRCh38/hg38) was obtained from the UCSC 
Genome Browser. Primer sequences can be provided upon re-
quest. The variant was submitted to the Locus Specific Database 
(variant ID 0000595122).
3 |  RESULTS
None of the patients tested showed microdeletion of ELN, 
LIMK1, and D7S613.
A novel heterozygous nonsense mutation (c.160G>T 
(p.(Gly54*)), RNA not analyzed) was identified at ELN exon 
3: chr7:74,036,581 (GRCh38/hg38) among II‐2, III‐1, and 
III‐2, but not in III‐3 (Figures 1 and 3a). This mutation gen-
erated a stop codon and suggested a disease‐causing muta-
tion for SVAS. A point mutation c.‐38C>T in 5' UTR in ELN 
exon1 at chr7:74,028,150 (GRCh38/hg38) was detected in 
II‐2, III‐1, III‐2, and III‐3, irrespective of SVAS phenotype. 
II‐2 had a homozygous mutation while III‐1, III‐2, and III‐3 
had heterozygous mutations (Figures 1 and, 3b).
4 |  DISCUSSION
To date, 66 types of ELN mutations have been reported in 
familial or sporadic SVAS, which includes point mutations 
or microdeletions (Hayano et al., 2019). The family with 
SVAS presented in this report demonstrates that the af-
fected arteries, severities, and clinical course can be varia-
ble among members with the same ELN mutation. Although 
the mother of the proband (II‐2) had no life‐threatening 
event until 15 years of age when she underwent patch aor-
toplasty for SVAS and gave birth to 3 children, the proband 
(III‐1) and her younger brother (III‐2) died suddenly in 
early infancy. Myocardial ischemia caused by coronary 
artery stenosis due to elastin arteriopathy has been impli-
cated in sudden death in SVAS (Vaideeswar & Regi, 2015). 
However, no apparent narrowing of the coronary arteries 
was noted on echocardiography and/or contrast cardiac CT 
in any of the infants. VT could have been associated with 
the fatal outcome as VT had actually been demonstrated in 
the proband.
It is worth noting that the ELN mutation identified in this 
family was associated with a serious clinical course, includ-
ing rapidly progressive narrowing of supravalvular portion 
of the aorta, critically hypoplastic PA, and sudden death in 
early infancy. In Case III‐2, SVAS was suspected as early as 
in fetal life, supported by fetal Doppler echocardiographic 
finding of accelerated LVOT flow velocity. In Case III‐2, 
narrowing of the supravalvular region of the aorta was al-
ready observed immediately after birth, which rapidly pro-
gressed during the next few months. These findings indicate 
F I G U R E  3  (a) DNA sequencing identified mutations in II‐2, III‐1, and III‐2 in comparison to CTRL and III‐3. The identified point mutation 
in exon 3 of ELN, which generated a stop codon (c.160G>T (p.(Gly54*)), NM_000501.2). (b) The identified SNPs in 5'‐UTR of ELN in exon 1 
(c.‐38C>T). II‐2 has homozygous SNPs, while III‐1, III‐2, and III‐3 have heterozygous SNPs
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that significant narrowing of aortic lumen may develop in 
fetal or neonatal life, therefore fetal echocardiography might 
be useful for screening of transmission of the mutated gene 
in SVAS.
In severe form of SVAS, which is indicated by increased 
or rapidly progressive PG through outflow tract, patch aor-
toplasty might be considered. However, it should be recog-
nized that these patients are very sensitive to hypotension 
and bradycardia induced by anesthesia even for diagnostic 
imaging. In our two fatal cases, hypoplastic PA could have 
been a risk factor even with patch aortoplasty for supra 
aortic lesions. The procedure could have resulted in shift 
of the interventricular septum and oppression against the 
LV because of persistent hypertension of the right ventri-
cle. In the present family, the third baby had neither SVAS 
nor stenosis of the other arteries, including PA. It was in-
teresting that he had complicated aortic arch anomalies, 
vascular ring, as well as external anomalies. The reason 
for the development of these rare anomalies and relation 
to SVAS is unclear. To date, no cases have been reported, 
in which SVAS and vascular ring develop within the same 
pedigree.
Genetically, the mutation c.160G>T (p.(Gly54*)) in exon 
3 of ELN introduced a stop codon in II‐2, III‐1, and III‐2. This 
mutation is a novel mutation with highly pathogenic trunca-
tion. Mechanistically the mutation is anticipated to lead to 
nonsense‐mediated decay and haploinsufficiency in the SVAS 
proband. Molecular basis of SVAS is still unknown, however, 
it has been reported that activation of integrin ß3 caused ab-
normal accumulation of smooth muscle cells and vascular 
stenosis (Misra et al., 2016). The c.‐38C>T mutation in ELN 
has been previously reported in SVAS with a combination 
of another mutation; however, its pathological significance 
was unclear (Metcalfe et al., 2000). The c.‐38C>T mutation 
did not segregate with the SVAS phenotype in our case and 
it was in the list of single nucleotide polymorphisms (SNPs, 
rs41410045). We concluded that it was not pathogenic. It is 
of note that even with the identical mutations in ELN, II‐2 
recovered from SVAS after the surgery while III‐1 and III‐2 
resulted in sudden death. One possibility is that homozygous 
SNPs potentially serve as a protective allele.
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